18 kDa Translocator protein (TSPO); Benzoxazolone; Peripheral benzodiazepine receptor (PBR)
Indexed keywords
(2 OXO 4 PHENYL 1,3 BENZOXAZOL 3(2H) YL)ACETIC ACID;
(2 OXO 5 PHENYL 1,3 BENZOXAZOL 3(2H) YL)ACETIC ACID;
(2 OXO 6 PHENYL 1,3 BENZOXAZOL 3(2H) YL) ACETIC ACID;
(5 BROMO 2 OXO 1,3 BENZOXAZOL 3(2H) YL)ACETIC ACID;
(7 BROMO 2 OXO 1,3 BENZOXAZOL 3(2H) YL)ACETIC ACID;
18 KDA TRANSLOCATOR PROTEIN LIGANDS;
2 (2 OXO 5 PHENYL 1,3 BENZOXAZOL 3(2H) YL) N PHENYL ACETAMIDE;
2 (2 OXO 5 PHENYL 1,3 BENZOXAZOL 3(2H) YL) N,N DIPROPYLACETAMIDE;
2 (2 OXO 5 PHENYL 1,3 BENZOXAZOL 3(2H) YL)ACETAMIDE;
2 (5 BROMO 2 OXO 1,3 BENZOXAZOL 3(2H) YL) N METHYL N PHENYLACETAMIDE;
2 (5 CHLORO 2 OXO 1,3 BENZOXAZOL 3(2H) YL) N METHYL N PHENYLACETAMIDE;
2 [5 (3 METHOXYPHENYL) 2 OXO 1,3 BENZOXAZOL 3(2H) YL] N METHYL N PHENYLACETAMIDE;
2 [5 (4 METHOXYPHENYL) 2 OXO 1,3 BENZOXAZOL 3(2H) YL] N METHYL N PHENYLACETAMIDE;
2 AMINO 4 BROMOPHENOL;
2 AMINO 6 BROMOPHENOL;
2 NITROBIPHENYL 3 OL;
3 (2 OXO 2 PHENYLETHYL) 5 PHENYL 1,3 BENZOXAZOL 2(3H) ONE;
3 [2 [METHYL(PHENYL)AMINO]ETHYL] 5 PHENYL 1,3 BENZOXAZOL 2(3H) ONE;
4 AMINOBIPHENYL 3 OL;
4 NITROBIPHENYL 3 OL;
4 PHENYL 1,3 BENZOXAZOL 2(3H) ONE;
5 BROMO 1,3 BENZOXAZOL 2(3H) ONE;
5 PHENYL 1,3 BENZOXAZOL 2(3H) ONE;
6 AMINOBIPHENYL 3 OL;
6 NITROBIPHENYL 3 OL;
6 PHENYL 1,3 BENZOXAZOL 2(3H) ONE;
7 BROMO 1,3 BENZOXAZOL 2(3H) ONE;
BENZOXAZOLE DERIVATIVE;
DIAZEPAM;
FLUMAZENIL;
GUM TRAGACANTH;
N (3 CHLOROPHENYL) N METHYL 2 (2 OXO 5 PHENYL 1,3 BENZOXAZOL 3(2H) YL)ACETAMIDE;
N (3 METHOXYPHENYL) N METHYL 2 (2 OXO 5 PHENYL 1,3 BENZOXAZOL 3(2H) YL)ACETAMIDE;
N (4 CHLOROPHENYL) N METHYL 2 (2 OXO 5 PHENYL 1,3 BENZOXAZOL 3(2H) YL)ACETAMIDE;
N (4 METHOXYPHENYL) N METHYL 2 (2 OXO 5 PHENYL 1,3 BENZOXAZOL 3(2H) YL)ACETAMIDE;
N [2 (HYDROXYMETHYL)PHENYL] N METHYL 2 (2 OXO 5 PHENYL 1,3 BENZOXAZOL 3(2H) YL)ACETAMIDE;
N [2 [(DIMETHYLAMINO)METHYL]PHENYL] N METHYL 2 (2 OXO 5 PHENYL 1,3 BENZOXAZOL 3(2H) YL)ACETAMIDE;
N [3 (HYDROXYMETHYL)PHENYL] N METHYL 2 (2 OXO 5 PHENYL 1,3 BENZOXAZOL 3(2H) YL)ACETAMIDE;
N [3 [(DIMETHYLAMINO)METHYL]PHENYL] N METHYL 2 (2 OXO 5 PHENYL 1,3 BENZOXAZOL 3(2H) YL)ACETAMIDE;
N [4 (HYDROXYMETHYL)PHENYL] N METHYL 2 (2 OXO 5 PHENYL 1,3 BENZOXAZOL 3(2H) YL)ACETAMIDE;
N [4 [(DIMETHYLAMINO)METHYL]PHENYL] N METHYL 2 (2 OXO 5 PHENYL 1,3 BENZOXAZOL 3(2H) YL)ACETAMIDE;
N BENZYL N METHYL 2 (2 OXO 5 PHENYL 1,3 BENZOXAZOL 3(2H) YL)ACETAMIDE;
N METHYL 2 (2 OXO 1,3 BENZOXAZOL 3(2H) YL) N PHENYLACETAMIDE;
N METHYL 2 (2 OXO 4 PHENYL 1,3 BENZOXAZOL 3(2H) YL) N PHENYLPROPANAMIDE;
N METHYL 2 (2 OXO 5 PHENOXY 1,3 BENZOXAZOL 3(2H) YL) N PHENYLACETAMIDE;
N METHYL 2 (2 OXO 5 PHENYL 1,3 BENZOXAZOL 3(2H) YL) N (PYRIDIN 2 YL)ACETAMIDE;
N METHYL 2 (2 OXO 5 PHENYL 1,3 BENZOXAZOL 3(2H) YL) N (PYRIDIN 3 YL)ACETAMIDE;
N METHYL 2 (2 OXO 5 PHENYL 1,3 BENZOXAZOL 3(2H) YL) N (PYRIDIN 4 YL)ACETAMIDE;
N METHYL 2 (2 OXO 5 PHENYL 1,3 BENZOXAZOL 3(2H) YL) N PHENYLACETAMIDE;
N METHYL 2 (2 OXO 6 PHENYL 1,3 BENZOXAZOL 3(2H) YL) N PHENYLPROPANAMIDE;
N METHYL 2 (2 OXO 7 PHENYL 1,3 BENZOXAZOL 3(2H) YL) N PHENYLPROPANAMIDE;
N METHYL 2 [2 OXO 5 (PYRIDIN 2 YL) 1,3 BENZOXAZOL 3(2H) YL] N PHENYLACETAMIDE;
N METHYL 2 [2 OXO 5 (PYRIDIN 3 YL) 1,3 BENZOXAZOL 3(2H) YL] N PHENYLACETAMIDE;
N METHYL 2 [2 OXO 5 (PYRIDIN 4 YL) 1,3 BENZOXAZOL 3(2H) YL] N PHENYLACETAMIDE;
N METHYL 2 [2 OXO 5 [3 (TRIFLUOROMETHYL)PHENYL] 1,3 BENZOXAZOL 3(2H) YL] N PHENYLACETAMIDE;
N METHYL 2 [2 OXO 5 [4 (TRIFLUOROMETHYL)PHENYL] 1,3 BENZOXAZOL 3(2H) YL] N PHENYLACETAMIDE;
N METHYL 2 [5 [METHYL(PHENYL)AMINO] 2 OXO 1,3 BENZOXAZOL 3(2H) YL] N PHENYLACETAMIDE;
N METHYL 3 (2 OXO 5 PHENYL 1,3 BENZOXAZOL 3(2H) YL) N PHENYLPROPANAMIDE;
N METHYL 4 (2 OXO 5 PHENYL 1,3 BENZOXAZOL 3(2H) YL) N PHENYLPROPANAMIDE;
N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE;
TERT BUTYL(2 OXO 5 PHENYL 1,3 BENZOXAZOL 3(2H) YL) ACETIC ACID;
TERT BUTYL(2 OXO 5 PHENYL 1,3 BENZOXAZOL 3(2H) YL)ACETIC ACID;
TERT BUTYL(2 OXO 6 PHENYL 1,3 BENZOXAZOL 3(2H) YL) ACETIC ACID;
TERT BUTYL(5 BROMO 2 OXO 1,3 BENZOXAZOL 3(2H) YL) ACETIC ACID;
TERT BUTYL(7 BROMO 2 OXO 1,3 BENZOXAZOL 3(2H) YL)ACETIC ACID;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
AREA UNDER THE CURVE;
ARTICLE;
BINDING AFFINITY;
BINDING SITE;
BRAIN CORTEX;
CHEMICAL STRUCTURE;
CONTROLLED STUDY;
DRUG BIOAVAILABILITY;
DRUG DESIGN;
DRUG POTENCY;
DRUG SOLUBILITY;
DRUG STABILITY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
HUMAN;
HYDROGEN BOND;
HYDROPHOBICITY;
KIDNEY;
MALE;
MAXIMUM PLASMA CONCENTRATION;
NONHUMAN;
PHARMACOPHORE;
PLASMA CLEARANCE;
RAT;
STRUCTURE ACTIVITY RELATION;
TIME TO MAXIMUM PLASMA CONCENTRATION;
TRANQUILIZING ACTIVITY;
V. Papadopolous, M. Baraldi, T.R. Guilarte, T.B. Knudsen, J.-J. Lacapère, P. Lindemann, M.D. Norenberg, D. Nutt, A. Weizman, M.-R. Zhang, and M. Gavish Trends Pharmacol. Sci. 27 2006 402
V. Papadopoulos, H. Amri, N. Boujrad, C. Cascio, M. Culty, M. Garnier, M. Hardwick, H. Li, B. Vidic, A.S. Brown, J.L. Reversa, J.M. Bernassau, and K. Drieu Steroids 62 1997 21
R. Rupprecht, G. Rammes, D. Eser, T.C. Baghai, C. Schüle, C. Nothdurfter, T. Troxler, C. Gentsch, H.O. Kalkman, F. Chaperon, V. Uzunov, K.H. McAllister, V. Bertaina-Anglade, C.D. La Rochelle, D. Tuerck, A. Floesser, B. Kiese, M. Schumacher, R. Landgraf, F. Holsboer, and K. Kucher Science 325 2009 490
G. Campiani, V. Nacci, I. Fiorini, M.P. De Filippis, A. Garofalo, S.M. Ciani, G. Greco, E. Novellino, D.C. Williams, D.M. Zisterer, M.J. Woods, C.M. Mihai, C. Manzoni, and T. Mennini J. Med. Chem. 39 1996 3435
G. Tarzia, A. Duranti, G. Gatti, G. Piersanti, A. Tontini, S. Rivara, A. Lodola, P.V. Plazzi, M. Mor, S. Kathuria, and D. Piomelli ChemMedChem 1 2006 130
S. Taneda, K. Kamata, H. Hayashi, N. Toda, K. Seki, A. Sakushima, S. Yoshino, K. Yamaki, M. Sakata, Y. Mori, and A.K. Suzuki J. Health Sci. 50 2004 133
G. Primofiore, F. Da Settimo, S. Taliani, F. Simorini, M.P. Patrizi, E. Novellino, G. Greco, E. Abignente, B. Costa, B. Chelli, and C. Martini J. Med. Chem. 2004 1852 47